These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17582083)

  • 1. Heparin-induced thrombocytopenia associated with fondaparinux.
    Warkentin TE; Maurer BT; Aster RH
    N Engl J Med; 2007 Jun; 356(25):2653-5; discussion 2653-5. PubMed ID: 17582083
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 3. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 4. Fondaparinux-associated heparin-induced thrombocytopenia.
    Bhatt VR; Aryal MR; Shrestha R; Armitage JO
    Eur J Haematol; 2013 Nov; 91(5):437-41. PubMed ID: 23905719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT.
    Warkentin TE; Sheppard JA; Manheim JC
    Thromb Haemost; 2014 Dec; 112(6):1319-22. PubMed ID: 25319237
    [No Abstract]   [Full Text] [Related]  

  • 6. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 8. Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal.
    Elalamy I; Tribout B
    J Thromb Haemost; 2008 Jul; 6(7):1242-3; author reply 1243-6. PubMed ID: 19330935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adrenal vein thrombosis in heparin-induced thrombocytopenia].
    Bölter S; Meier M; Roeren T
    Rofo; 2000 Jan; 172(1):100-1. PubMed ID: 10719472
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
    Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
    Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute adrenocortical insufficiency due to heparin-induced thrombocytopenia with subsequent bilateral haemorrhagic infarction of the adrenal glands.
    Weyrich P; Balletshofer B; Hoeft S; Häring HU; Nawroth PP
    Vasa; 2001 Nov; 30(4):285-8. PubMed ID: 11771214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombosis of ovarian veins in puerperium associated with heparin-induced thrombocytopenia type II].
    Winkler M; Delpiano B; Rath W
    Zentralbl Gynakol; 2000; 122(1):49-52. PubMed ID: 10785951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
    Matsuo T; Matsuo M; Ouga-Maruyama S
    Thromb Haemost; 2001 Oct; 86(4):1115-6. PubMed ID: 11686333
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
    Blackmer AB; Oertel MD; Valgus JM
    Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia associated with fondaparinux.
    Chong BH; Chong JJ
    Clin Adv Hematol Oncol; 2010 Jan; 8(1):63-5. PubMed ID: 20351686
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed-onset heparin-induced thrombocytopenia and thrombosis.
    Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.
    Tvito A; Bakchoul T; Rowe JM; Greinacher A; Ganzel C
    Am J Hematol; 2015 Jul; 90(7):675-8. PubMed ID: 25683147
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia and phlegmasia cerulea dolens of the upper limb successfully treated with fondaparinux.
    Filis K; Lagoudianakis EE; Pappas A; Kotzadimitriou K; Genetzakis M; Sigala F; Theodorou D; Manouras A
    Acta Haematol; 2008; 120(3):190-1. PubMed ID: 19129690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.